Like in other hematopoietic neoplasms [91], TET2, DNMT3A, and IDH2 mutations occur frequently across PTCL subtypes, although certain mutations seem to be confined to T-cell lymphoma cases [92] (see Table 2 for overview). The gene discussed is IDH2; the disease is hematopoietic and lymphoid cell neoplasm.